Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE KLIPVELD from Ukkel, company number BE1016117263, closed financial year 2025 with a result of € 44,385 after tax. For that financial year PHARMACIE KLIPVELD recorded a gross margin of € 64,720 and equity of € 46,885. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 46,885
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 44,385
Profit after tax over the fiscal year.
€ 29,508
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 44,385.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 18,106
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 50,774
€ 11,463 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 35,779
Supplier invoices still open on the last day of the fiscal year.
€ 13,401
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to PHARMACIE KLIPVELD?
What happened at PHARMACIE KLIPVELD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 44,385. Source: NBB ↗
- New establishment in Ukkel. KBO
- KARIM BADAOUI became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 10,738 in corporate taxes since 2025.
A new publication or filing at PHARMACIE KLIPVELD? We notify you, reason included.
Follow PHARMACIE KLIPVELDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE KLIPVELD is KARIM BADAOUI.
Directors
According to the 2025 annual accounts
KARIM BADAOUI
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Klipveldstraat 49
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1016.117.263
- VAT number
- BE 1016.117.263
- Registered office
- Klipveldstraat 49, 1180 Ukkel
- Names & denominations
- PHARMACIE KLIPVELD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 2024
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten